These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 7967735

  • 1. Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.
    Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W.
    Leukemia; 1994 Nov; 8(11):1906-13. PubMed ID: 7967735
    [Abstract] [Full Text] [Related]

  • 2. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W.
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [Abstract] [Full Text] [Related]

  • 3. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
    Rubio-Félix D, Giraldo MP, Perella M, Gimeno J, Franco E, Giralt M.
    Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
    Berer A, Jäger E, Sagaster V, Streubel B, Wimazal F, Sperr WR, Welterman A, Schwarzinger I, Frommlet F, Haas OA, Valent P, Lechner K, Geissler K, Ohler L.
    Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063
    [Abstract] [Full Text] [Related]

  • 11. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H, Haas PS, Kunzmann R, Schulte-Mönting J, Lübbert M.
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [Abstract] [Full Text] [Related]

  • 12. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C, Acevedo S, Bengio R, Arrossagaray G, Watman N, Rossi N, García J, Flores G, Goldztein S, Larripa I.
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [Abstract] [Full Text] [Related]

  • 13. Myelodysplastic syndromes: a community hospital-based study of prognostic factors and International Prognostic Scoring System.
    Mirza I, Garzón R, Burns J, Edwards L, Fernandez-Cymering C, Kloss R.
    Conn Med; 2001 Aug; 65(8):455-63. PubMed ID: 11550445
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
    Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R.
    Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.